Why the study?
Does vaccination with a naturally attenuated Portuguese ASF isolate reduce death rate and virus load in domestic pigs challenged with a highly virulent southern African isolate?
Does vaccination with a naturally attenuated Portuguese ASF isolate reduce death rate and virus load in domestic pigs challenged with a highly virulent southern African isolate?
Vaccination with a naturally attenuated European ASF isolate delayed mortality but failed to provide complete protection against a highly virulent southern African isolate in domestic pigs.
Answers are grounded in this paper and cite their sources.
Partial protection in pigs offers no basis for deployment; leaves open pursuit of fully protective ASF vaccines.
African swine fever (ASF) is a mostly fatal viral infection of domestic pigs for which there is no vaccine available. The disease is endemic to most of sub-Saharan Africa, causes severe losses and threatens food security in large parts of the continent. Naturally occurring attenuated ASF viruses have been tested as vaccine candidates, but protection was variable depending on the challenge virus. In this study, the virulence of two African isolates, one from a tick vector and the other from an indigenous pig, was determined in domestic pigs to identify a potential vaccine strain for southern Africa. Neither isolate was suitable as the tick isolate was moderately virulent and the indigenous pig virus was highly virulent. The latter was subsequently used as heterologous challenge in pigs first vaccinated with a naturally attenuated isolate previously isolated in Portugal. Although a statistically significant reduction in death rate and virus load was observed compared with unvaccinated pigs post-challenge, all pigs succumbed to infection and died.
No takes yet. Share an insight, caveat, or question.
Souto et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: